FindTrial
Sign In

Canceled by the investigator. Clinical Application of Ligament Advanced Reinforcement System (LARS) in Assisting Reconstruction of Joint Function after Tumor Hemiarthroplasty

Clinical application of LARS ligament assisted joint function reconstruction - Clinical application of LARS ligament assisted joint function reconstruction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065095
Enrollment
Unknown
Registered
2022-10-27
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant bone tumor

Interventions

experience group:Reconstruction of joint function after tumor type hemiarthroplasty assisted by LARS ligament

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with benign and malignant bone tumors treated in our department who underwent tumor segment resection; 2. Artificial artificial weights were used to build bone defects; 3. LARS ligament was used for soft tissue repair and reconstruction; 4. The patient data is complete and the follow-up time is more than 12 months.

Exclusion criteria

Exclusion criteria: 1. Patients treated with total joint replacement; 2. Patients whose lesions are located in the femoral head or neck and reconstructed with common femoral head prosthesis; 3. Patients who underwent single bone resection and double joint replacement; 4. Patients who underwent amputation of the affected limb within a short period (<6 months) after surgery; 5. Patients lost during follow-up.

Design outcomes

Primary

MeasureTime frame
Joint function of affected side;—

Countries

China

Contacts

Public ContactQing Liu

Xiangya Hospital of Central South University

liuqing_csu@csu.edu.cn18207425349

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026